KEGG: ssn:SSON_2336
NADH-quinone oxidoreductase subunit K (nuoK) is a membrane-bound component of bacterial respiratory chain Complex I (NADH dehydrogenase I) in Shigella sonnei. It functions as an integral part of the electron transport chain with EC number 1.6.99.5. In Shigella sonnei strain Ss046, nuoK corresponds to Uniprot accession number Q3YZT1 and is encoded by the nuoK gene (SSON_2336) . The protein consists of 100 amino acids and contains multiple hydrophobic regions consistent with its transmembrane topology. The amino acid sequence is: MIPLQHGLILAAILFIL GLTGLVIRRNLLFMLIG LEIMINSALAFVVAGS YWGQTDGQVMYILAISLAAAEASIGLALLLQL HRRRQNLNIDSVSEMRG .
NuoK plays a crucial role in energy metabolism by participating in the electron transfer process and potentially in proton translocation across the membrane, which is essential for energy conservation in bacterial cells.
NuoK functions as part of Complex I (NADH:quinone oxidoreductase), which catalyzes the first step in the respiratory electron transport chain. This process involves:
Oxidation of NADH to NAD+, which is essential for maintaining cellular redox balance
Transfer of electrons from NADH to quinones in the membrane
Generation of proton motive force through proton translocation across the membrane
Contributing to ATP synthesis via oxidative phosphorylation
While nuoK is a relatively small subunit, it provides structural integrity to the membrane domain of Complex I and likely participates in forming the proton translocation pathway. The protein's hydrophobic nature allows it to span the bacterial inner membrane multiple times, positioning it perfectly to contribute to the proton pumping machinery .
While nuoK has not been directly characterized as a virulence factor, its function within the respiratory chain has important implications for Shigella sonnei pathogenicity:
Energy metabolism: As part of the electron transport chain, nuoK contributes to energy generation needed to power various virulence mechanisms.
Adaptation to host environments: Effective respiratory function supports bacterial adaptation to different oxygen and nutrient conditions encountered during infection.
Stress response support: Proper energy metabolism underpins bacterial responses to host defense mechanisms.
Shigella sonnei has emerged as a significant global pathogen, particularly in developed countries where it has become the predominant species causing shigellosis . This bacterium employs numerous virulence mechanisms including a type VI secretion system (T6SS) that helps it outcompete other Enterobacteriaceae, production of colicins and mucinases, and expression of proteins that destabilize host intestinal epithelial integrity . The metabolic capabilities supported by proteins like nuoK enable the bacterium to successfully colonize and cause disease in host environments.
Research involving recombinant nuoK typically employs several methodological approaches:
Protein expression and purification:
Cloning the nuoK gene into expression vectors
Expression in bacterial host systems
Purification using affinity chromatography
Size exclusion chromatography for final purification
Structural studies:
X-ray crystallography to determine three-dimensional structure
Cryo-electron microscopy for structural analysis within larger Complex I
Circular dichroism spectroscopy to analyze secondary structure
Functional assays:
NADH oxidation assays using spectrophotometric methods
Membrane potential measurements
Reconstitution into liposomes to study proton translocation
Quinone reduction assays
Interaction studies:
Cross-linking experiments with other subunits of Complex I
Co-immunoprecipitation assays
Blue native PAGE to analyze complex formation
Because nuoK is a membrane protein, special consideration must be given to maintaining proper detergent concentrations during purification and ensuring appropriate membrane-like environments for structural and functional studies .
The structural features of nuoK include:
Transmembrane topology:
Multiple hydrophobic regions consistent with transmembrane helices
Spans the bacterial inner membrane multiple times
Contains charged residues at strategic positions that may participate in proton translocation
Structural elements:
Predominantly alpha-helical secondary structure in the transmembrane regions
Small loops connecting transmembrane segments
Terminal regions that may interact with neighboring subunits
Positioning within Complex I:
Located in the membrane domain of the complex
Forms part of the proton translocation machinery
Interacts with other membrane subunits to maintain structural integrity
While high-resolution structural information specifically for Shigella sonnei nuoK is limited, comparative analysis with homologous proteins suggests it adopts a similar fold to other nuoK subunits in bacterial Complex I structures .
NuoK plays a specialized role in the electron transfer mechanisms of Complex I, though it does not directly bind prosthetic groups involved in electron transfer (such as iron-sulfur clusters or FMN). Its contribution involves:
Structural support for the proton-pumping machinery:
Maintains alignment of key residues involved in proton translocation
Forms part of the proton channel within the membrane domain
Stabilizes conformational states required during catalysis
Conformational coupling:
Participates in conformational changes that couple electron transfer in the hydrophilic domain to proton pumping in the membrane domain
Contains residues that may form part of the proton pathway
Quinone interaction environment:
While not directly binding quinones, nuoK's position places it near the quinone binding site
May influence the local environment of the quinone binding pocket
Could participate in proton delivery to/from the quinone binding site
Studies of similar NADH-quinone oxidoreductases have shown the existence of multiple ubiquinone binding sites (UQI and UQII) that act as intermediates for electron transfer . These binding sites interact with FAD and facilitate the transfer of electrons from NADH to ubiquinone in a process that nuoK helps structurally support.
Optimizing the expression and purification of membrane proteins like nuoK presents significant challenges. The following methodological approaches have proven effective:
Expression systems:
Bacterial systems: Modified E. coli strains designed specifically for membrane protein expression
Cell-free expression systems: Allow direct incorporation into provided lipid environments
Fusion partners: MBP, SUMO, or Mistic fusions to enhance solubility and expression
Expression conditions:
Lower induction temperatures (16-20°C)
Reduced inducer concentrations
Extended expression times (overnight to 48 hours)
Specialized media formulations
Extraction and solubilization:
Detergent screening: n-Dodecyl β-D-maltoside (DDM), n-Octyl-β-D-glucopyranoside (OG), Lauryl maltose neopentyl glycol (LMNG)
Lipid addition during solubilization
Careful optimization of detergent concentration
Purification strategy:
Multi-step affinity purification
Size exclusion chromatography as final polishing step
Maintaining appropriate detergent concentration throughout
Use of lipid additives to maintain protein stability
Quality assessment:
Circular dichroism to confirm secondary structure
Thermal stability assays
Functional activity measurements
Negative stain electron microscopy
For structural studies specifically, additional considerations include reconstitution into nanodiscs or amphipols for cryo-EM studies and screening for conditions that promote crystal formation .
The relationship between nuoK activity and antibiotic resistance in Shigella sonnei is multifaceted:
Energy dependency of resistance mechanisms:
Many antibiotic resistance mechanisms, particularly efflux pumps, require energy
As part of the respiratory chain, nuoK contributes to the energy generation needed for these resistance mechanisms
Fluoroquinolone and ciprofloxacin resistance, which is increasingly common in S. sonnei, often involves energy-dependent efflux systems
Metabolic adaptations under antibiotic stress:
Bacteria may alter their energy metabolism when exposed to antibiotics
Changes in respiratory complex expression or activity could be part of these adaptive responses
Alternative electron transport pathways may be utilized under stress conditions
Redox balance and antibiotic efficacy:
Many antibiotics induce oxidative stress
NADH:quinone oxidoreductases influence cellular redox balance
Changes in nuoK function could affect how cells respond to antibiotic-induced oxidative stress
Ciprofloxacin and fluoroquinolone-resistant S. sonnei has already intensified the global spread and burden of antimicrobial resistance . Understanding the role of metabolic components like nuoK in supporting resistance mechanisms could lead to new therapeutic strategies that target both the resistance machinery and its energetic requirements.
Investigating nuoK's role in host-pathogen interactions requires specialized methodological approaches:
Genetic manipulation in infection models:
Construction of nuoK deletion or point mutation strains
Complementation with wild-type or modified nuoK
Inducible expression systems to control nuoK levels during infection
Reporter fusions to monitor expression in host environments
Cell culture infection models:
Intestinal epithelial cell lines for invasion assays
Macrophage infection models to assess intracellular survival
Co-culture systems with host immune cells
Measurement of bacterial respiratory activity within host cells
Metabolic profiling during infection:
Stable isotope labeling to track metabolic flux
Transcriptomic analysis of respiratory genes during infection
Comparison of wild-type and nuoK-modified strains in vivo
Real-time monitoring of energy metabolism during host cell invasion
Animal infection models:
Mouse models of Shigella infection
Tracking bacterial dissemination and persistence
In vivo competition assays between wild-type and nuoK-modified strains
Response to antibiotic treatment
Systems biology approaches:
Integration of transcriptomic and metabolomic data
Network analysis of infection-specific metabolic adaptations
Modeling of host-pathogen metabolic interactions
Identification of infection-specific vulnerabilities in bacterial metabolism
These approaches enable researchers to understand how respiratory function, supported by nuoK, influences Shigella sonnei's ability to establish infection, survive host defenses, and cause disease.
The nuoK protein, as part of the respiratory chain, contributes significantly to Shigella sonnei's ability to adapt to varying host environments:
Oxygen availability adaptation:
Different host tissues present varying oxygen tensions
The respiratory chain containing nuoK helps bacteria adapt to these different conditions
Alternative electron transport pathways may be activated in low-oxygen environments
Energy harvesting in different nutrient conditions:
Host environments vary in available carbon sources
Respiratory flexibility allows utilization of different electron donors
Efficient energy extraction supports survival in nutrient-limited conditions
Response to host defense mechanisms:
Host cells generate reactive oxygen species (ROS) as defense
Proper function of nuoK and related proteins helps manage oxidative stress
Maintenance of redox balance supports bacterial survival
Adaptation to pH variations:
Different host compartments have varying pH
Proton translocation activities involving nuoK affect bacterial pH homeostasis
Adaptive changes in respiratory complex expression may occur in different pH environments
Competition with host microbiota:
S. sonnei uses T6SS to outcompete other bacteria
Energy from respiratory processes supports competitive mechanisms
Metabolic flexibility provides advantage in niche occupation
S. sonnei has shown increasing prevalence globally, replacing S. flexneri in many regions . This shifting pattern may relate to S. sonnei's adaptive capabilities, including its metabolic flexibility in different environments, supported by proteins like nuoK in the respiratory chain.
Functional characterization of recombinant nuoK requires carefully designed assays:
Reconstitution approaches:
Liposome reconstitution with other Complex I subunits
Nanodiscs to provide native-like membrane environment
Proteoliposomes for proton pumping assays
NADH oxidation assays:
Spectrophotometric tracking of NADH absorption at 340 nm
Coupled enzyme assays for enhanced sensitivity
Oxygen consumption measurements using respirometry
Inhibitor sensitivity profiling (rotenone, piericidin A)
Proton translocation measurements:
pH-sensitive fluorescent dyes (ACMA, pyranine)
Ion-selective electrodes for direct proton measurement
Membrane potential indicators (DiSC3, JC-1)
Time-resolved measurements to capture kinetics
Quinone reduction assays:
Direct measurement of quinone reduction
Artificial electron acceptors to isolate specific activities
Stopped-flow methods for rapid kinetics
Conformational change detection:
Site-directed spin labeling combined with EPR
FRET-based approaches with strategically placed fluorophores
Hydrogen-deuterium exchange mass spectrometry
For accurate results, functional assays typically require the presence of other Complex I subunits, as nuoK alone would not show the complete functional activities associated with the intact complex .
Multiple structural biology approaches offer complementary insights into nuoK:
X-ray crystallography:
Challenges: Membrane proteins are difficult to crystallize
Approaches: Lipidic cubic phase crystallization, antibody fragment co-crystallization
Resolution potential: Can achieve atomic resolution (1.5-3Å)
Insights: Precise atomic positions, bound ligands, water molecules
Cryo-electron microscopy (cryo-EM):
Advantages: No crystallization required, captures multiple conformational states
Particularly valuable for studying nuoK in the context of the entire Complex I
Can visualize lipid interactions in nanodiscs or amphipols
Recent advances allow near-atomic resolution
Nuclear magnetic resonance (NMR):
Applications: Dynamics studies, ligand binding, smaller protein domains
Limitations: Size constraints make full nuoK structure challenging
Can provide information on mobile regions not well-resolved by other methods
Molecular dynamics simulations:
Complement experimental structures with dynamic information
Probe proton translocation pathways
Model interactions with lipids and other subunits
Investigate conformational changes during catalytic cycle
Hydrogen-deuterium exchange mass spectrometry:
Maps solvent accessibility and conformational changes
Identifies dynamic regions and interaction interfaces
Compatible with detergent-solubilized proteins
The most comprehensive structural understanding comes from integrating multiple techniques, with each method contributing different aspects of nuoK structure and function .
Genetic approaches provide powerful tools for understanding nuoK's role:
Gene knockout/knockdown strategies:
CRISPR-Cas9 genome editing for clean deletions
Transposon mutagenesis for random insertions
Antisense RNA approaches for partial suppression
Inducible systems for temporal control of expression
Site-directed mutagenesis approaches:
Targeting conserved residues predicted to be functionally important
Introduction of reporter tags for localization studies
Creation of conditional mutants
Charge-altering mutations to probe proton translocation pathways
Phenotypic assessments:
Growth curve analysis under different conditions
Oxygen consumption measurements
Membrane potential determination
Antibiotic sensitivity profiling
Invasion and intracellular survival in cell culture models
Virulence testing in appropriate animal models
Complementation studies:
Rescue with wild-type nuoK
Cross-species complementation to assess functional conservation
Domain swapping to identify critical regions
Controlled expression levels to determine threshold requirements
These approaches allow researchers to connect nuoK function directly to pathogenesis, identifying how respiratory chain components contribute to Shigella sonnei's ability to cause disease and adapt to selective pressures like antibiotic exposure .
Studying inhibitors of Complex I containing nuoK requires specialized approaches:
Inhibitor screening methodologies:
High-throughput screening using NADH oxidation assays
Fragment-based screening approaches
Structure-based virtual screening
Phenotypic screening using growth inhibition
Mechanism of action studies:
Competition assays with known inhibitors
Site-directed mutagenesis to identify binding sites
Photoaffinity labeling to map binding locations
Biophysical methods to measure binding (ITC, SPR, MST)
Selectivity determination:
Comparison with mammalian Complex I inhibition
Cross-species activity profiling
Testing against isolated bacterial strains
Cytotoxicity assessment against host cells
Efficacy evaluation:
Determination of minimum inhibitory concentrations
Time-kill assays
Post-antibiotic effect measurement
Synergy testing with conventional antibiotics
Activity in biofilm models
In vivo assessment:
Pharmacokinetic/pharmacodynamic studies
Efficacy in animal infection models
Toxicity evaluation
Resistance development monitoring
Several classes of inhibitors may target Complex I and affect nuoK function, including quinone analogs, phenothiazines, and natural products . These compounds could represent starting points for developing new antimicrobials against increasingly resistant Shigella sonnei strains.
Systems biology provides frameworks to understand nuoK's role in the broader context:
Network analysis approaches:
Protein-protein interaction networks including nuoK
Metabolic network modeling with respiratory chain components
Regulatory networks affecting and affected by respiration
Signal transduction pathways connected to energy status
Multi-omics integration:
Transcriptomics: Gene expression changes in response to nuoK perturbation
Proteomics: Changes in protein abundance and post-translational modifications
Metabolomics: Metabolic consequences of altered electron transport
Fluxomics: Changes in metabolic flux distributions
Computational modeling methods:
Constraint-based models (e.g., flux balance analysis)
Kinetic models of respiratory chain function
Agent-based models of host-pathogen interactions
Machine learning approaches to identify patterns in multi-omics data
Experimental validation strategies:
Targeted validation of model predictions
Testing synthetic lethality predictions
Metabolic rescue experiments
Engineering of synthetic circuits to probe system properties
Integration with pathogenesis mechanisms:
Connecting energy metabolism to virulence factor expression
Modeling adaptation to host environments
Understanding resilience mechanisms against host defenses
Predicting vulnerabilities for therapeutic targeting
These approaches recognize that nuoK doesn't function in isolation but is part of an integrated network that collectively contributes to Shigella sonnei's ability to cause disease .
Several research avenues show promise for targeting nuoK therapeutically:
Structure-based drug design:
High-resolution structures of nuoK within Complex I
Identification of druggable pockets
Virtual screening for potential inhibitors
Fragment-based approaches to develop novel compounds
Combination therapy approaches:
Identifying synergistic effects between respiratory inhibitors and conventional antibiotics
Targeting multiple components of energy metabolism simultaneously
Exploiting metabolic vulnerabilities created by nuoK inhibition
Narrow-spectrum therapeutic development:
Exploiting structural differences between bacterial and human complexes
Targeting pathogen-specific features of nuoK
Developing compounds with selectivity for Shigella over commensal bacteria
Alternative inhibition strategies:
Peptide inhibitors mimicking interaction interfaces
Allosteric inhibitors affecting conformational changes
Disruption of complex assembly
Targeting regulatory mechanisms affecting nuoK expression
Resistance mitigation approaches:
Understanding potential resistance mechanisms
Multi-target inhibitors to reduce resistance development
Evolutionary constraints analysis to identify conserved targets
The growing global burden of antimicrobial resistance in Shigella sonnei, particularly to fluoroquinolones and ciprofloxacin, underscores the importance of developing novel therapeutic strategies targeting essential components of energy metabolism like nuoK .
Environmental and epidemiological factors shape nuoK evolution in Shigella sonnei:
Anthropogenic influences:
Antibiotic usage patterns driving selection pressure
Changing sanitation conditions altering transmission dynamics
Global travel facilitating the spread of specific lineages
Urbanization creating new ecological niches
Host-related factors:
Immune system pressures selecting for certain variants
Dietary changes affecting available nutrient sources
Host microbiome competition influencing metabolic requirements
Different host populations exerting varying selective pressures
Ecological considerations:
Water quality and environmental persistence
Temperature and climate effects on bacterial metabolism
Food production and processing environments
Animal reservoirs and cross-species transmission
Competitive microbial dynamics:
Competition with other Shigella species and E. coli variants
Horizontal gene transfer potentials in different environments
Bacteriophage predation selecting for particular genotypes
Cross-protection from related environmental bacteria
Studies suggest that improved sanitation has reduced cross-immunization from Plesiomonas shigelliodes (which shares the same O-antigen as S. sonnei), potentially contributing to S. sonnei's increased prevalence . Understanding these factors can help predict future evolutionary trajectories and inform public health strategies.
Despite advances in understanding nuoK, several critical knowledge gaps remain:
Structural understanding:
High-resolution structures of Shigella sonnei nuoK are lacking
Detailed proton translocation pathways remain incompletely characterized
Conformational dynamics during the catalytic cycle need further elucidation
Specific lipid interactions that may influence function are poorly understood
Functional characterization:
Precise contribution to proton pumping mechanism remains unclear
Regulatory mechanisms controlling expression under different conditions
Potential moonlighting functions beyond respiration
Interactions with other cellular components outside of Complex I
Role in pathogenesis:
Direct connections between respiratory function and virulence expression
Contribution to persistence in host environments
Role in antibiotic tolerance and resistance
Adaptation to host-specific environments
Therapeutic potential:
Druggability assessment of nuoK and associated regions
Specificity determinants for selective targeting
Resistance mechanisms that might emerge
In vivo efficacy of respiratory chain targeting
Addressing these knowledge gaps will require interdisciplinary approaches combining structural biology, biochemistry, microbiology, and computational methods. The complex nature of membrane proteins and their integration into larger complexes makes nuoK particularly challenging to study, but its importance in bacterial physiology and potential as a therapeutic target make it worthy of continued investigation.
Accelerating nuoK research requires integrative approaches that combine multiple disciplines:
Technological integration:
Combining cryo-EM and crystallography data for complete structural models
Integrating computational simulations with experimental structures
Developing new tools for membrane protein expression and characterization
High-throughput screening methods adapted for membrane proteins
Multi-disciplinary collaborations:
Structural biologists working with microbiologists
Drug discovery specialists collaborating with infectious disease experts
Systems biologists partnering with biochemists
Computational scientists working alongside experimental researchers
Data integration strategies:
Creating comprehensive databases of respiratory chain components
Developing machine learning approaches to predict structure-function relationships
Establishing standardized assays for comparing results across studies
Implementing FAIR (Findable, Accessible, Interoperable, Reusable) data principles
Translational research approaches:
Connecting basic research findings to clinical applications
Developing model systems that better recapitulate human infection
Establishing industry-academic partnerships for drug development
Engaging public health stakeholders to address global antimicrobial resistance
The emergence of Shigella sonnei as a globally significant pathogen, particularly with increasing antibiotic resistance, creates urgency for research that can lead to new therapeutic and preventive strategies . Integrative approaches that build on our understanding of fundamental components like nuoK represent a promising path forward.